Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region
OBJECTIVES: To examine the relationship between antibody status and cycle threshold (Ct) values, the prognostic value of the latter for COVID-19 patients, and the inter-assay comparability of SARS-CoV-2 Ct values. METHODS: In 347 COVID-19 inpatients, SARS-CoV-2 Ct values (via reverse transcription-q...
| Autores: | , , , , , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2021 |
| País: | España |
| Institución: | Universidad del País Vasco |
| Repositorio: | Addi. Archivo Digital para la Docencia y la Investigación |
| OAI Identifier: | oai:addi.ehu.eus:10810/53138 |
| Acceso en línea: | http://hdl.handle.net/10810/53138 |
| Access Level: | acceso abierto |
| Palabra clave: | COVID-19 Ct value RT-qPCR SARS-CoV-2 anti-SARS-CoV-2 antibodies |
| id |
ES_ab0a7362bf0b76ac585c38fbe4d84f4e |
|---|---|
| oai_identifier_str |
oai:addi.ehu.eus:10810/53138 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence regionMarkewitz, RobertTorge, AntjeWandinger, Klaus-PeterPauli, DanielaDargvainiene, JustinaFranke, AndreBujanda Fernández de Pierola, LuisMarimón Ortiz de Zarate, José MaríaBañales Asurmendi, Jesús MaríaGutiérrez Stampa, María AngelesNafría, BeatrizJunker, RalfCOVID-19Ct valueRT-qPCRSARS-CoV-2anti-SARS-CoV-2 antibodiesOBJECTIVES: To examine the relationship between antibody status and cycle threshold (Ct) values, the prognostic value of the latter for COVID-19 patients, and the inter-assay comparability of SARS-CoV-2 Ct values. METHODS: In 347 COVID-19 inpatients, SARS-CoV-2 Ct values (via reverse transcription-quantitative polymerase chain reaction) on admission were compared between 2 assays and correlated with the antibody response (in the course of the disease), the clinical course and the time since onset of symptoms. RESULTS: Ct values for 2 of 3 target genes showed significant differences between the 2 assays used (P=0.012 and P<0.0001). Ct values were significantly higher for antibody positive patients (P<0.0001) and positively correlated with the amount of time since onset of symptoms (R: 0.332-0.363; P<0.001). Patients with fatal outcomes showed higher viral loads than survivors (P<0.0001). CONCLUSIONS: Ct values depend strongly on assay used and target gene examined and should not be used as quantitative values to guide therapeutic or diagnostic decisions. The inverse association between antibody status and viral load suggests that antibodies contribute to the elimination of the virus, independent of the outcome, which is influenced by the viral load on admission and might depend more strongly on other parts of the immune response.Elsevier202120212021info:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10810/53138reponame:Addi. Archivo Digital para la Docencia y la Investigacióninstname:Universidad del País VascoIngléshttps://www.sciencedirect.com/science/article/pii/S1201971221005701?via%3Dihubinfo:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/3.0/es/2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )Atribución-NoComercial-SinDerivadas 3.0 Españaoai:addi.ehu.eus:10810/531382026-06-18T09:23:17Z |
| dc.title.none.fl_str_mv |
Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region |
| title |
Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region |
| spellingShingle |
Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region Markewitz, Robert COVID-19 Ct value RT-qPCR SARS-CoV-2 anti-SARS-CoV-2 antibodies |
| title_short |
Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region |
| title_full |
Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region |
| title_fullStr |
Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region |
| title_full_unstemmed |
Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region |
| title_sort |
Analysis of SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction cycle threshold values vis-à-vis anti-SARS-CoV-2 antibodies from a high incidence region |
| dc.creator.none.fl_str_mv |
Markewitz, Robert Torge, Antje Wandinger, Klaus-Peter Pauli, Daniela Dargvainiene, Justina Franke, Andre Bujanda Fernández de Pierola, Luis Marimón Ortiz de Zarate, José María Bañales Asurmendi, Jesús María Gutiérrez Stampa, María Angeles Nafría, Beatriz Junker, Ralf |
| author |
Markewitz, Robert |
| author_facet |
Markewitz, Robert Torge, Antje Wandinger, Klaus-Peter Pauli, Daniela Dargvainiene, Justina Franke, Andre Bujanda Fernández de Pierola, Luis Marimón Ortiz de Zarate, José María Bañales Asurmendi, Jesús María Gutiérrez Stampa, María Angeles Nafría, Beatriz Junker, Ralf |
| author_role |
author |
| author2 |
Torge, Antje Wandinger, Klaus-Peter Pauli, Daniela Dargvainiene, Justina Franke, Andre Bujanda Fernández de Pierola, Luis Marimón Ortiz de Zarate, José María Bañales Asurmendi, Jesús María Gutiérrez Stampa, María Angeles Nafría, Beatriz Junker, Ralf |
| author2_role |
author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
COVID-19 Ct value RT-qPCR SARS-CoV-2 anti-SARS-CoV-2 antibodies |
| topic |
COVID-19 Ct value RT-qPCR SARS-CoV-2 anti-SARS-CoV-2 antibodies |
| description |
OBJECTIVES: To examine the relationship between antibody status and cycle threshold (Ct) values, the prognostic value of the latter for COVID-19 patients, and the inter-assay comparability of SARS-CoV-2 Ct values. METHODS: In 347 COVID-19 inpatients, SARS-CoV-2 Ct values (via reverse transcription-quantitative polymerase chain reaction) on admission were compared between 2 assays and correlated with the antibody response (in the course of the disease), the clinical course and the time since onset of symptoms. RESULTS: Ct values for 2 of 3 target genes showed significant differences between the 2 assays used (P=0.012 and P<0.0001). Ct values were significantly higher for antibody positive patients (P<0.0001) and positively correlated with the amount of time since onset of symptoms (R: 0.332-0.363; P<0.001). Patients with fatal outcomes showed higher viral loads than survivors (P<0.0001). CONCLUSIONS: Ct values depend strongly on assay used and target gene examined and should not be used as quantitative values to guide therapeutic or diagnostic decisions. The inverse association between antibody status and viral load suggests that antibodies contribute to the elimination of the virus, independent of the outcome, which is influenced by the viral load on admission and might depend more strongly on other parts of the immune response. |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021 2021 2021 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10810/53138 |
| url |
http://hdl.handle.net/10810/53138 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
https://www.sciencedirect.com/science/article/pii/S1201971221005701?via%3Dihub |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-nd/3.0/es/ Atribución-NoComercial-SinDerivadas 3.0 España |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/3.0/es/ Atribución-NoComercial-SinDerivadas 3.0 España |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Elsevier |
| publisher.none.fl_str_mv |
Elsevier |
| dc.source.none.fl_str_mv |
reponame:Addi. Archivo Digital para la Docencia y la Investigación instname:Universidad del País Vasco |
| instname_str |
Universidad del País Vasco |
| reponame_str |
Addi. Archivo Digital para la Docencia y la Investigación |
| collection |
Addi. Archivo Digital para la Docencia y la Investigación |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869416233836740608 |
| score |
15,300719 |